BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience

K. Rihawi, D. Giannarelli, D. Galetta, A. Delmonte, M. Giavarra, D. Turci, M. Garassino, M. Tiseo, F. Barbieri, S. Panni, A. Ardizzoni

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)e57-e59
JournalJournal of Thoracic Oncology
Volume14
Issue number3
Publication statusPublished - 2019

Cite this

Rihawi, K., Giannarelli, D., Galetta, D., Delmonte, A., Giavarra, M., Turci, D., Garassino, M., Tiseo, M., Barbieri, F., Panni, S., & Ardizzoni, A. (2019). BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience. Journal of Thoracic Oncology, 14(3), e57-e59.